Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 6Unspecified Adult Solid Tumor, Protocol Specific 3Neoplasms 2Lung Neoplasms 2Hypocalcemia 2Breast Neoplasms 2Vitamin D Deficiency 1Tuberous Sclerosis 1Tobacco Use Disorder 1Thyroiditis 1Thyroid Nodule 1Thyroid Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Pneumonia 1Pinealoma 1Pancreatic Neoplasms 1Osteoporosis 1Oligodendroglioma 1Obesity 1Neuroectodermal Tumors, Primitive 1Neoplasm Metastasis 1Mouth Neoplasms 1Meningioma 1Melanoma 1Medulloblastoma 1Leukemia 1Hyperthyroidism 1Hyperparathyroidism 1Goiter 1

Interventions

Everolimus 12Sirolimus 10Cannabidiol 3ganaxolone 2Melatonin 2Activator Appliances 2radiprodil 1Vigabatrin 1Urination 1Simvastatin 1Propranolol 1Doxycycline 1Calcitriol 12-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Tuberous Sclerosis × Calcitriol × Clear all
NCT03140449 2017-05-04

Topical Rapamycin and Calcitriol for Angiofibroma of Tuberous Sclerosis

National Taiwan University Hospital

Phase 3 Completed
52 enrolled

Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡